Evidence‐practice gaps in P2Y(12) inhibitor use after hospitalisation for acute myocardial infarction: findings from a new population‐level data linkage in Australia

BACKGROUND: P2Y(12) inhibitor therapy is recommended for 12 months in patients hospitalised for acute myocardial infarction (AMI) unless the bleeding risk is high. AIMS: To describe real‐world use of P2Y(12) inhibitor therapy following AMI hospitalisation. METHODS: We used population‐level linked ho...

Descripción completa

Detalles Bibliográficos
Autores principales: Falster, Michael O., Schaffer, Andrea L., Wilson, Andrew, Nasis, Arthur, Jorm, Louisa R., Hay, Melanie, Leeb, Kira, Pearson, Sallie‐Anne, Brieger, David
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons Australia, Ltd 2022
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9306967/
https://www.ncbi.nlm.nih.gov/pubmed/32840951
http://dx.doi.org/10.1111/imj.15036

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9306967/
https://www.ncbi.nlm.nih.gov/pubmed/32840951
http://dx.doi.org/10.1111/imj.15036

Ejemplares similares